GlaxoSmithKline and Valeant announce US FDA approval of Potiga™ (ezogabine)
Media
GSK & VRX announced that the FDA has approved Potiga Tablets, a potassium channel opener, as treatment of partial-onset seizures in
18yo+.
https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-and-valeant-announce-us-fda-approval-of-potiga-ezogabine/
First published: 13 June 2011